H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 70 Citations 18,483 146 World Ranking 624 National Ranking 302
Medicine D-index 70 Citations 18,542 154 World Ranking 15808 National Ranking 8181


What is he best known for?

The fields of study he is best known for:

  • Gene
  • Virus
  • DNA

Christos J. Petropoulos mainly investigates Virology, Virus, Immunology, Viral disease and Drug resistance. His Virology study incorporates themes from Resistance mutation and Acquired immunodeficiency syndrome. His research in Virus intersects with topics in Phenotype, Reverse transcriptase, Recombinant virus and Sexual transmission.

His Immunology study integrates concerns from other disciplines, such as Regimen and Gene. The study incorporates disciplines such as V3 loop and Viral load in addition to Viral disease. Christos J. Petropoulos has included themes like Mutation, Protease inhibitor and Pharmacotherapy in his Drug resistance study.

His most cited work include:

  • Rapid evolution of the neutralizing antibody response to HIV type 1 infection (1078 citations)
  • Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies (681 citations)
  • Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. (604 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Virology, Virus, Immunology, Drug resistance and Viral disease. Christos J. Petropoulos interconnects Reverse transcriptase and Acquired immunodeficiency syndrome in the investigation of issues within Virology. His biological study spans a wide range of topics, including Mutation, Protease and Recombinant virus.

Immunology is closely attributed to Transmission in his study. His Drug resistance study also includes

  • Drug and related Gene,
  • Integrase inhibitor and related Raltegravir. Specifically, his work in Viral disease is concerned with the study of Sida.

He most often published in these fields:

  • Virology (60.73%)
  • Virus (40.31%)
  • Immunology (30.89%)

What were the highlights of his more recent work (between 2012-2021)?

  • Virology (60.73%)
  • Drug resistance (24.61%)
  • Internal medicine (10.99%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Virology, Drug resistance, Internal medicine, Breast cancer and Oncology. His study in Virus and Viral replication falls under the purview of Virology. His Virus research is multidisciplinary, incorporating elements of Gene duplication and HIV Protease Inhibitor.

His study in Drug resistance is interdisciplinary in nature, drawing from both Cabotegravir, Protease, Integrase inhibitor, Integrase and Pre-exposure prophylaxis. His studies in Internal medicine integrate themes in fields like Viral load and Emtricitabine. His Oncology research also works with subjects such as

  • Metastatic breast cancer which intersects with area such as Immunology,
  • Cancer that intertwine with fields like Kinase activity.

Between 2012 and 2021, his most popular works were:

  • Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure. (110 citations)
  • Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds (52 citations)
  • HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer (48 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Virus

His primary areas of investigation include Drug resistance, Virology, Protease, Genetics and Integrase. The various areas that Christos J. Petropoulos examines in his Drug resistance study include EC50, Hepatitis C Virus NS3/4A Protease Inhibitors, Catalytic triad and Potency. Many of his research projects under Virology are closely connected to Telaprevir and Boceprevir with Telaprevir and Boceprevir, tying the diverse disciplines of science together.

His research integrates issues of Raltegravir Potassium, Amino acid and Gene in his study of Virus. The concepts of his Protease study are interwoven with issues in Tropism, Nucleoside Reverse Transcriptase Inhibitor, Reverse transcriptase, Viral evolution and Co-receptor. As part of one scientific family, Christos J. Petropoulos deals mainly with the area of Integrase, narrowing it down to issues related to the Dolutegravir, and often Point mutation, Mutation and Viral load.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Douglas D. Richman;Terri Wrin;Susan J. Little;Christos J. Petropoulos.
Proceedings of the National Academy of Sciences of the United States of America (2003)

1544 Citations

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Christos J. Petropoulos;Neil T. Parkin;Kay L. Limoli;Yolanda S. Lie.
Antimicrobial Agents and Chemotherapy (2000)

949 Citations

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies

James M. Binley;Terri Wrin;Bette Korber;Michael B. Zwick.
Journal of Virology (2004)

883 Citations

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Steven G. Deeks;Terri Wrin;Teri Liegler;Rebecca Hoh.
The New England Journal of Medicine (2001)

833 Citations

Time trends in primary HIV-1 drug resistance among recently infected persons.

Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu.
JAMA (2002)

585 Citations

Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy

Florencia Pereyra;Marylyn M. Addo;Daniel E. Kaufmann;Yang Liu.
The Journal of Infectious Diseases (2008)

561 Citations

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

Frederick M. Hecht;Robert M. Grant;Christos J. Petropoulos;Beth Dillon.
The New England Journal of Medicine (1998)

551 Citations

Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser.
JAMA (1999)

440 Citations

Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1

Aran F. Labrijn;Pascal Poignard;Aarti Raja;Michael B. Zwick.
Journal of Virology (2003)

438 Citations

Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.

Jeannette M. Whitcomb;Wei Huang;Signe Fransen;Kay Limoli.
Antimicrobial Agents and Chemotherapy (2007)

427 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christos J. Petropoulos

David C. Montefiori

David C. Montefiori

Duke University

Publications: 175

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 168

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 159

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 129

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 125

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 101

Bette T. Korber

Bette T. Korber

Los Alamos National Laboratory

Publications: 97

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 97

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 96

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 92

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 87

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 83

Davey M. Smith

Davey M. Smith

University of California, San Diego

Publications: 76

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 74

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 73

Deenan Pillay

Deenan Pillay

University College London

Publications: 71

Something went wrong. Please try again later.